With extensive experience in industrial microbiology, Institut Mérieux contributes to serving medicine and public health across the globe. For the fight against infectious diseases and cancer, it imagines and develops new approaches in the fields of diagnostics, immunotherapy, food safety and nutrition. With 5 complementary companies— bioMérieux, Transgene, Mérieux NutriSciences, ABL Inc. and Mérieux Développement—Institut Mérieux provide answers to the new challenges of public health globally. Institut Mérieux employs more 21,000 people worldwide and generated net sales of 4 billion Euros.